Showing results 28 to 45 of 45
< previous
| Title | Author(s) | Issue Date | |
|---|---|---|---|
| 2011 | |||
PD-L1 expression in patients with anaplastic thyroid carcinoma: prevalence and outcome Proceeding/Conference:Thyroid | 2018 | ||
| 2016 | |||
Phase I trial of Recombinant Human Arginase 1 (PEG-BCT-100) combined with Capecitabine and Oxaliplatin (PACOX) in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma Proceeding/Conference:Symposium of Pegylated Human Recombinant Arginase in the Treatment of Cancers and other human Disease, Hong Kong | 2017 | ||
Real-world Experience with Cabozantinib Proceeding/Conference:Ipsen Hepatocellular carcinoma (HCC) Asia Scientific Meeting, Seoul, South Korea | 2019 | ||
| 2016 | |||
Serum microRNAs as potential biomarker for screening colorectal cancer patients Proceeding/Conference:Annals of Oncology | 2015 | ||
Staging System for Hepatocellular Carcinoma: How Should it Affect the Management Proceeding/Conference:Asian-Pacific Hepato-Pancreato-Biliary Association, Singapore | 2015 | ||
Survival analysis of hepatic resection for breast cancer metastases in Chinese women Proceeding/Conference:Hepatology International | 2013 | ||
Systemic treatment of metastatic neuroendocrine tumours to the liver Proceeding/Conference:Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA) | 2013 | ||
| 2012 | |||
The Clinical Guidelines Evolution in HCC from BCLC to HKLC - Where Does cTACE Fit In ? Proceeding/Conference:APPLE 2016 (Asia-Pacific Primary Liver Cancer Expert Meeting, 2016) | 2016 | ||
The Evolving Landscape of Immunotherapy-Based Combinations in Hepatocellular Carcinoma - What Should We Be Considering? Proceeding/Conference:Taiwan Liver Cancer Association, 2019 Post-ASCO Highlight and Real World Data Review, Kaohsiung, Taiwan | 2019 | ||
The power of targeted agents in the management of advanced RCC Proceeding/Conference:Asian Congress of Urology of the Urological Association of Asia | 2010 | ||
The Role of Anti-EGFR and Tumor Location in 1st line Treatment of Metastatic Colorectal Cancer Proceeding/Conference:The Oncology Symposium on mCRC Management, Ho Chi Minh City, Vietnam | 2017 | ||
The Use of Cabozantinib in Advanced HCC: CELESTIAL Experiences Proceeding/Conference:Ipsen Expert Panel Meeting in Hepatocellular Carcinoma, Hong Kong | 2019 | ||
Treatment stratification for patients with hepatocellular carcinoma according to HCC stage Proceeding/Conference:Asian Pacific Digestive Week 2015 (APDW 2015) | 2015 | ||
What Are The Latest Advances in Hepatobiliary and Pancreatic Cancers in 2018? Proceeding/Conference:Hepatobiliary Meeting, Hong Kong Sanatorium & Hospital, Hong Kong | 2018 |